focus -WSS

focus

author：Wikipedia 2025-09-29 00:39:02 - browse：2

Sen. Bill Cassidy, R-La., listens during a Senate Health, Education, Labor, and Pensions Committee hearing. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Stefani Reynolds/The New York Times via AP

WASHINGTON — The top-ranking Republican on the Senate health committee is launching an investigation into two hospitals’ use of a government program that provides big drug discounts in return for serving low-income communities.

At the foundation of the debate over the so-called 340B program is whether Congress intended it to directly benefit low-income and uninsured patients or whether it was meant to help finance those hospitals, which could use the money as they see fit to add services.

Hospitals say they use the money to provide such services as free care for uninsured patients, free vaccinations, mental health clinics, and community health programs. But drugmakers have long argued that hospitals and chain pharmacies abuse the program and divert its cash flows to other uses. They also say the 340B program fuels the consolidation of health care systems as hospitals buy up private doctor practices to expand the 340B revenue stream.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： David Ricks of Eli Lilly: best biopharma CEO of 2023

knowledge

focus

WSS

Baltimore teen accused of firing into crowd during block party mass shooting

Carvykti CAR

Beware the threat of staffing cuts at the CDC

ActiGraph execs on goal of drug approvals with digital endpoints

Clinical trials must include more disabled people

Baltimore teen accused of firing into crowd during block party mass shooting

focus

focus

focus

Alkermes shareholders re

Grail spinoff by Illumina should end disastrous merger attempt

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What STAT readers think about the FDA and patient advocacy

Bright Health sells Medicare Advantage business to Molina

Liz Cheney makes 1st public comment since Trump's election interference indictments

Affirmative action in medical school literally saved lives

Prime Medicine, Myeloid Therapeutics clash over genome

Virginia high school admissions case could be legal follow

New definition of a human embryo proposed amid rapid advances

leisure time

Why health records don't always know when patients are dead

Living with Hashimoto's and celiac disease, and med school, too

Medicare Advantage beneficiaries sue Humana over algorithm use

Grail spinoff by Illumina should end disastrous merger attempt

Cancer drug shortages' outsize impact on ovarian cancer patients

SEC charges former device maker CEO with $41 million fraud

hotspot

knowledge

focus

focus